AV

Alice Vickers

Biotech Investment Associate at Forbion | PhD Stem Cells & Genetics

Netherlands

Investor
VC

Invests in

Stages:

Series A
Seed

Locations:

United Kingdom

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Cell Biology
Genetics
Research
Teamwork
Communication
Customer Service
Time Management
Social Media
Microsoft Office
Leadership
Data Analysis
Molecular Biology
Microsoft Excel

Education

Lists including Alice

AM
Al
AF
AV

Based in Amsterdam

273 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

F
Forbion

2023

  • Associate

    2024

  • Analyst

    2023 - 2024

    Forbion invests in life sciences companies that are active in the bio-pharmaceutical space. Forbion manages €3 billion across multiple fund strategies that cover all stages of drug development.

IC
INKEF Capital

2021 - 2023

  • Healthcare Investor

    2021 - 2023

    Inkef is a €500M VC fund, backing promising early stage Healthcare and Technology companies in Europe. Board Observer: NMD Pharma, Salvia BioElectronics, Audion Therapeutics

SL
Syncona Limited

2020 - 2020

  • Project Advisor

    2020 - 2020

    Syncona is a leading venture capital fund focused on founding, building and funding global leaders in life science.

MV
M Ventures

2019 - 2019

  • Fellow

    2019 - 2019

    Strategic, corporate venture arm of Merck KGaA.

IF
Innovation Forum

2016 - 2019

  • President (formerly Business Development Director)

    2016 - 2019

    The Innovation Forum is an accelerator for healthcare ventures.

SJ
St John's Laboratory Ltd

2015 - 2016

  • Marketing & Business Development Executive

    2015 - 2016

IC
Imperial College London

2015 - 2015

  • Research Scientist

    2015 - 2015

    Prof. Mustafa Djamgoz lab.